Finance

Lists
Why is 51S down 15,38%?
Dive Deeper
51S:FRA
Cynata Therapeutics Ltd
0,0055 €
-15,38%
(-0,0010) 1D
14-окт., 08:03:02 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 51S...
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
4,79 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,24 €
52-wk low
0,00 €
No. of employees
0
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
4,79 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,24 €
52-wk low
0,00 €
No. of employees
0
News stories
From web sources and news partners
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
Sector-
Websitecynata.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
855,81 миң
855,81 миң
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
2,77 млн
2,77 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,69 млн
1,69 млн
-763,69 миң
-763,69 миң
Operating expense
2,22 млн
2,22 млн
2,63 млн
2,63 млн
Total operating expenses
2,22 млн
2,22 млн
2,63 млн
2,63 млн
Operating income
-1,36 млн
-1,36 млн
-2,63 млн
-2,63 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,33 млн
-1,33 млн
-3,29 млн
-3,29 млн
EBT excluding unusual items
-1,33 млн
-1,33 млн
-2,62 млн
-2,62 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
425,31 миң
425,31 миң
527,43 миң
527,43 миң
Net income
-1,33 млн
-1,33 млн
-3,29 млн
-3,29 млн
Net profit margin
-155,55%
-155,55%
-
-
Earnings per share
-
-
-
-
Interest and investment income
30,33 миң
30,33 миң
9,42 миң
9,42 миң
Interest expense
-
-
-
-
Net interest expenses
30,33 миң
30,33 миң
9,42 миң
9,42 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,30 млн
-1,30 млн
-2,56 млн
-2,56 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору